| 2021-11-09 |
详情>>
股本变动：
变动后总股本2425.23万股
|
| 2021-11-09 |
详情>>
业绩披露：
2021年三季报(累计)每股收益-0.07美元,归母净利润-177.3万美元,同比去年增长67.37%
|
| 2021-10-25 |
股东大会：
将于2021-11-29召开股东大会
会议内容 ▼▲
- 1.To consider and vote upon a proposal to adopt the agreement and plan of merger, dated as of August 30, 2021, with Synaptics Incorporated, a Delaware corporation, and Osprey Merger Sub, Inc., a wholly-owned subsidiary of Synaptics (“Merger Sub”), pursuant to which Merger Sub will be merged with and into the Company, with the Company surviving as a wholly-owned subsidiary of Synaptics (which we refer to as the “the merger agreement proposal”);
2.To consider and vote on a non-binding, advisory proposal to approve specified compensation that may be paid or become payable to the Company’s named executive officers based on or otherwise relates to the merger (which we refer to as the “the merger-related executive compensation proposal”);
3.To consider and vote on a proposal to adjourn or postpone the special meeting to a later date or time, if necessary, to solicit additional proxies if there are insufficient votes at the time of the special meeting to adopt the merger agreement (which we refer to as the “adjournment proposal”);
4.To transact any other business that may properly be brought before the special meeting, or any adjournments or postponements of the special meeting, by or at the direction of the Company’s board of directors.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-08-30 |
复牌提示：
2021-08-30 07:57:31 停牌，复牌日期 2021-08-30 08:30:00
|
| 2021-08-09 |
详情>>
业绩披露：
2021年中报每股收益-0.07美元,归母净利润-174.2万美元,同比去年增长50.83%
|
| 2021-08-02 |
财报披露：
美东时间 2021-08-02 盘前发布财报
|
| 2021-05-10 |
详情>>
业绩披露：
2021年一季报每股收益-0.06美元,归母净利润-134.3万美元,同比去年增长45.52%
|
| 2021-04-30 |
股东大会：
将于2021-06-14召开股东大会
会议内容 ▼▲
- 1.Election of Directors. To elect seven directors, Shira Fayans Birenbaum, Ofer Elyakim, Thomas A. Lacey, Cynthia L. Paul, Yair Seroussi, Norman P. Taffe and Kenneth H. Traub, each to serve until the 2021 annual meeting of stockholders, and until their successors are elected and qualified, subject to their earlier resignation or removal;
2.Selection of Independent Auditors. To ratify the appointment of Kost Forer Gabbay-Kasierer, a member of Ernst & Young Global, as the Company’s independent auditors for the year ending December 31, 2021;
3.Compensation of the Named Executive Officers. Advisory vote to approve the Company’s named executive officers compensation;
4.To transact such other business as may properly come before the annual meeting and any adjournment or postponement thereof.
|
| 2021-03-15 |
详情>>
业绩披露：
2018年年报每股收益-0.09美元,归母净利润-195.7万美元,同比去年增长34.83%
|
| 2021-03-15 |
详情>>
业绩披露：
2020年年报每股收益-0.29美元,归母净利润-679万美元,同比去年增长-470.59%
|
| 2020-11-09 |
详情>>
业绩披露：
2019年三季报(累计)每股收益-0.05美元,归母净利润-110.3万美元,同比去年增长32.62%
|
| 2020-11-09 |
详情>>
业绩披露：
2020年三季报(累计)每股收益-0.23美元,归母净利润-543.4万美元,同比去年增长-392.66%
|
| 2020-08-10 |
详情>>
业绩披露：
2020年中报每股收益-0.15美元,归母净利润-354.3万美元,同比去年增长-123.25%
|
| 2020-05-11 |
详情>>
业绩披露：
2020年一季报每股收益-0.11美元,归母净利润-246.5万美元,同比去年增长-131.24%
|
| 2020-04-29 |
股东大会：
将于2020-06-10召开股东大会
会议内容 ▼▲
- 1.Election of Directors. To elect seven directors, Ofer Elyakim, Thomas A. Lacey, Cynthia Paul, Gabi Seligsohn, Yair Seroussi, Norman P. Taffe and Kenneth H. Traub, each to serve until the 2021 annual meeting of stockholders, and until their successors are elected and qualified, subject to their earlier resignation or removal;
2.Amendment and Restatement of the 1993 Employee Stock Purchase Plan. To approve an amendment and restatement of the Company’s 1993 Employee Stock Purchase Plan to increase the number of shares of common stock reserved for issuance thereunder from 4,800,000 shares to 5,300,000 shares;
3.Selection of Independent Auditors. To ratify the appointment of Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global, as the Company’s independent auditors for the year ending December 31, 2020;
4.Compensation of the Named Executive Officers. Advisory vote to approve the Company’s named executive officers compensation;
5.To transact such other business as may properly come before the annual meeting and any adjournment or postponement thereof.
|
| 2020-03-11 |
详情>>
业绩披露：
2019年年报每股收益-0.05美元,归母净利润-119万美元,同比去年增长39.19%
|
| 2019-05-06 |
股东大会：
将于2019-06-06召开股东大会
会议内容 ▼▲
- 1.Election of Directors. To elect seven directors, Ofer Elyakim, Thomas A. Lacey, Cynthia Paul, Gabi Seligsohn, Yair Seroussi, Norman P. Taffe and Kenneth H. Traub, each to serve until the 2020 annual meeting of stockholders, and until their successors are elected and qualified, subject to their earlier resignation or removal;
2.Amendment and Restatement of the Amended and Restated 2012 Equity Incentive Plan. To approve an amendment and restatement of the Company’s Amended and Restated 2012 Equity Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder from 3,750,000 shares to 5,250,000 shares;
3.Selection of Independent Auditors. To ratify the appointment of Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global, as the Company’s independent auditors for the year ending December 31, 2019;
4.Compensation of the Named Executive Officers. Advisory vote to approve the Company’s named executive officers compensation;
5.To transact such other business as may properly come before the annual meeting and any adjournment or postponement thereof.
|
| 2018-11-05 |
详情>>
内部人交易：
SEROUSSI YAIR共交易2笔
|
| 2018-04-12 |
股东大会：
将于2018-05-14召开股东大会
会议内容 ▼▲
- 1.Election of Directors. To elect eight directors, Ofer Elyakim, Thomas A. Lacey, Cynthia Paul, Gabi Seligsohn, Yair Seroussi, Norman P. Taffe, Patrick Tanguy and Kenneth H. Traub, each to serve until the 2019 annual meeting of stockholders, and until their successors are elected and qualified, subject to their earlier resignation or removal;
2.Amendment and Restatement of the Amended and Restated 2012 Equity Incentive Plan. To approve an amendment and restatement of the Company’s Amended and Restated 2012 Equity Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder from 3,100,000 shares to 3,750,000 shares;
3.Selection of Independent Auditors. To ratify the appointment of Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global, as the Company’s independent auditors for the year ending December 31, 2018;
4.Compensation of the Named Executive Officers. Advisory vote to approve the Company’s named executive officers compensation;
5.To transact such other business as may properly come before the annual meeting and any adjournment or postponement thereof.
|
| 2017-04-10 |
股东大会：
将于2017-05-15召开股东大会
会议内容 ▼▲
- 1.Election of Directors. To elect seven directors, Ofer Elyakim, Thomas A. Lacey, Gabi Seligsohn, Yair Seroussi, Norman P. Taffe, Patrick Tanguy and Kenneth H. Traub, each to serve until the 2018 annual meeting of stockholders, and until their successors are elected and qualified, subject to their earlier resignation or removal;
2.Amendment and Restatement of the 2012 Equity Incentive Plan. To approve an amendment and restatement of the Company’s 2012 Equity Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder from 2,450,000 shares to 3,100,000 shares;
3.Selection of Independent Auditors. To ratify the appointment of Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global, as the Company’s independent auditors for the year ending December 31, 2017;
4.Compensation of the Named Executive Officers. Advisory vote to approve the Company’s named executive officers compensation;
5.Frequency of Executive Compensation Advisory Vote. To recommend, in a non-binding vote, whether a non-binding stockholder vote to approve the compensation of the Company’s named executive officers should occur every one, two or three years;
6.To transact such other business as may properly come before the annual meeting and any adjournment or postponement thereof.
|
| 2016-04-29 |
股东大会：
将于2016-06-06召开股东大会
会议内容 ▼▲
- 1.Election of Directors. To elect seven directors, Ofer Elyakim, Thomas A. Lacey, Gabi Seligsohn, Yair Seroussi, Norman P. Taffe, Patrick Tanguy and Kenneth H. Traub, each to serve until the 2017 annual meeting of stockholders, and until their successors are elected and qualified, subject to their earlier resignation or removal;
2. Amendment of Second Restated Certificate of Incorporation. To approve an amendment to the Company's Second Restated Certificate of Incorporation to eliminate 66 2/3 voting requirement for removal of a director without cause;
3.Amendment of Second Restated Certificate of Incorporation. To approve an amendment to the Company's Second Restated Certificate of Incorporation to add a provision to designate Delaware Chancery Court as the exclusive forum for certain legal actions;
4.Selection of Independent Auditors. To ratify the appointment of Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global, as the Company’s independent auditors for the year ending December 31, 2016;
5.Compensation of the Named Executive Officers. Advisory vote to approve the Company’s named executive officers compensation;
6.To transact such other business as may properly come before the annual meeting and any adjournment or postponement thereof.
|
| 2015-05-07 |
股东大会：
将于2015-06-08召开股东大会
会议内容 ▼▲
- 1. Election of Directors to Serve One-Year Term. To elect six directors, Ofer Elyakim, Thomas A. Lacey, Gabi Seligsohn, Yair Seroussi, Patrick Tanguy and Kenneth H. Traub, each to serve until the 2016 annual meeting of stockholders, and until their successors are elected and qualified, subject to their earlier resignation or removal;
2. Amendment and Restatement of Restated Certificate of Incorporation. To approve an amendment and restatement of the Company's Restated Certificate of Incorporation to eliminate supermajority voting rights contained therein and integrate into a single document all previously stockholder-approved amendments to the Restated Certificate of Incorporation;
3. Amendment and Restatement of Restated Certificate of Incorporation. To approve an amendment and restatement of the Company's Restated Certificate of Incorporation to add a provision to designate Delaware Chancery Court as the exclusive forum for certain legal actions;
4. Amendment and Restatement of the 2012 Equity Incentive Plan. To approve an amendment and restatement of the Company’s 2012 Equity Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder from 1,450,000 shares to 2,450,000 shares;
5. Amendment and Restatement of the 1993 Employee Stock Purchase Plan. To approve an amendment and restatement of the Company’s 1993 Employee Stock Purchase Plan to increase the number of shares of common stock reserved for issuance thereunder from 3,800,000 shares to 4,800,000 shares;
6. Selection of Independent Auditors. To ratify the appointment of Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global, as the Company’s independent auditors for the year ending December 31, 2015;
7. Compensation of the Named Executive Officers. Advisory vote to approve the Company’s named executive officers compensation;
8. To transact such other business as may properly come before the annual meeting and any adjournment or postponement thereof.
|
| 2014-04-30 |
股东大会：
将于2014-06-09召开股东大会
会议内容 ▼▲
- 1. Election of Class II Directors. To elect three Class II directors, Ofer Elyakim, Gabi Seligsohn and Yair Seroussi, each to serve until the 2015 annual meeting of stockholders (if Proposal 2 is approved) or until the 2017 annual meeting of stockholders (if Proposal 2 is not approved), and until their successors are elected and qualified, subject to their earlier resignation or removal;
2. Amendment of Restated Certificate of Incorporation. To approve the amendment of the Restated Certificate of Incorporation of the Company, as amended, to eliminate the classified structure of the Board of Directors;
3. Selection of Independent Auditors. To ratify the appointment of Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global, as the Company’s independent auditors for the year ending December 31, 2014;
4. Compensation of the Named Executive Officers. Advisory vote to approve the Company’s named executive officers compensation;
5. To transact such other business as may properly come before the annual meeting and any adjournment or postponement thereof.
|